Boothbay Fund Management’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Boothbay Fund Management’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,968	Closed	-$8.36K	–	2566
2023 Q1	$8.36K	Hold	11,968	–	–	﹤0.01%	2077
2022 Q4	$10.8K	Hold	11,968	–	–	﹤0.01%	1938
2022 Q3	$72K	Sell	11,968 -52,872	-82%	-$300K	﹤0.01%	2084
2022 Q2	$268K	Hold	64,840	–	–	0.01%	1544
2022 Q1	$246K	Hold	64,840	–	–	0.01%	1756
2021 Q4	$292K	Hold	64,840	–	–	0.01%	1277
2021 Q3	$302K	Sell	64,840 -20,073	-24%	-$106K	0.01%	1327
2021 Q2	$599K	Buy	84,913 +1,421	+2%	+$7.66K	0.02%	923
2021 Q1	$493K	Buy	+83,492	New	+$506K	0.02%	957
2020 Q3	–	Sell	-28,350	Closed	-$815K	–	1299
2020 Q2	$815K	Buy	+28,350	New	+$656K	0.06%	444

Boothbay Fund Management's STSA Position: Q2 2023 in Review

Boothbay Fund Management sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 11,968 shares — an estimated $8.36K sold.

Boothbay Fund Management first reported a position in STSA in Q2 2020 and held it in 10 quarters. The position peaked at $815K in Q2 2020. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Boothbay Fund Management reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Boothbay Fund Management sold 11,968 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $8.36K.
Boothbay Fund Management first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Boothbay Fund Management's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $815K in Q2 2020.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Boothbay Fund Management's 13F filing for Q2 2023, filed 14 Aug 2023.